management evaluates the products and businesses making up the company Steps in Analyzing the Current Business Portfolio 1. Identify key businesses making up the company 2. Assess the attractiveness of its various SBUs 3. Decide how much support each SBU deserves Steps in Analyzing the Current Business Portfolio Identify key businesses making up the company
Premium Marketing Strategic management
main competitors of Sony’s electronics SBU would be Samsung Electronics or Panasonic’s electronics business. Sony’s video game business faces major competition from the Microsoft gaming division and from Nintendo. Sony Music mainly competes with Universal Music Group and Warner Music Group. The main competitors of Sony Pictures Entertainment include Universal Studios‚ Warner Brothers Entertainment‚ but also The Walt Disney Studios. Sony’s Financial Services SBU competes mainly with the Nippon Life
Premium Sony Video game
create two alternative solutions‚ they are : 1. TheWarner Lambert should merge or work together with Pfizer. 2. Test still secret product against statins already on the market The Warner Lambert understand that the Merk (main competitor in statin product) has big strength and they know it is on to something big. But to play catch up in the market‚ it also knew it would need extra marketing muscle. Pfizer then the no.5 drugmaker is known for its sales and marketing prowess and have no statin of its own
Premium Marketing Strategic management Sales
Analysis Methods Porter’s Five Force in relation to Eli Lilly Threat of New Entrants Threat of new entrants is relatively high. Companies forming alliances are potential rivals. Even if earlier such company was not considered to be a threat‚ after merging with some research and development company or forming alliance with another pharmaceutical company it would become a rival to Eli Lilly. The threat is however weakened by significant research and development costs necessary to successfully
Premium Pharmacology Generic drug Pharmaceutical industry
Jason Caligagan Mr. Carrol SBU April 19‚ 2013 Humans take Control of Evolution Humans have only existed about 130‚ 000 years ago and we have recently evolved. Human activities are driving the evolution of other species in dramatic and often unexpected ways. Natural selection no longer affects us but we have effect it in many ways. Another way‚ we control the outcome of our race is "self-designed evolution” (Hawkings‚ 2009). Unnatural Selection takes part of our control of evolution. For
Premium Human Natural selection Stephen Hawking
1 2 STRICTLY CONFIDENTIAL ASSESSMENT SHEET FOR MARKETING EXECUTIVE 1. PERSONAL Name : Employee No. : Division : H.Q. : Date of Birth : Date of Joining : 2. TRAITS / QUALITIES Please assess the following traits / qualities in Rating Column as Excellent‚ Good‚ Fair or Poor. Also‚ allocate marks out of 10 for each of these traits (Excellent being 9 to 10‚ Good being 6 to 8‚ Fair being 3 to 5 and Poor being 1 to 2). |Sr No.
Premium Sales
Marketing Function to be a source of ‘Competitive Advantage’ for the SBU: as we move from a focus on “tactical” decisions with low exit costs and “local” impacts to strategic” decision which have higher exit costs and broader impacts on other functions‚ organizational effectiveness‚ the implementation of Business Strategy‚ and the LONG TERM profitability of the PRODUCT/LINE‚ MARKET‚ CATEGORY‚ BRAND or Strategic Business Unit (SBU). In addition to the development of a (set of) marketing strategy(ies)
Premium Marketing Strategic management
A Financial Ratio Quarterly Trend Analysis of: Bristol-Myers Squibb Company Stock symbol: BMY Listed on the New York Stock Exchange Introduction: The following report will include provide a financial quarterly trend analysis of Bristol-Myers Squibb Company (BMS) which was founded in 1989‚ and is based in New York City. This is a publicly traded company on the New York Stock Exchange (NYSE)‚ and their stock symbol is BMY. Bristol-Myers Squibb is currently “ranked 8th among 500 the
Premium Financial ratios Financial ratio
Chapter 21 Questions 1 through 7 1. On balance‚ do you think Merck is an ethical and socially responsible company? Why or why not? How about Pfizer? In my opinion‚ Merck is not an ethical and socially responsible company with introducing Vioxx into pharmaceutical market. Before the Vioxx approval by FDA‚ scientists from University of Pennsylvania found that the drug could bring some serious results such as cardiovascular‚ and there were many serious cardiovascular problems during testing
Premium Pharmaceutical industry Pharmacology Clinical trial
RANBAXY LABORATORIES LTD RESEARCH EQUITY RESEARCH July 10‚ 2008 RESULTS REVIEW Share Data Market Cap Price BSE Sensex Reuters Bloomberg Avg. Volume (52 Week) 52-Week High/Low Shares Outstanding Valuation Ratios (Consolidated) Year to 31 December 2008E EPS (Rs.) 14.7 EPS Growth (%) 27.8% PER (x) 36.6x EV/ Sales (x) 3.2x 19.2x EV/ EBITDA (x) Shareholding Pattern (%) Promoters FIIs Institutions Public & Others Relative Performance 700 600 500 400 300 200 Jul-07 Aug-07 Sep-07 Oct-07 Nov-07 Dec-07
Premium Ranbaxy Laboratories Revenue Generic drug